Fulgent Genetics, Inc. (FLGT) Tops Q1 EPS by 30c

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q1 EPS of ($0.22), $0.30 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $66.2 million versus the consensus estimate of $59.62 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
• Morgan Stanley course-corrects their semiconductor equipment outlook on demand